Literature DB >> 18070050

p53 and Ki-67 expression in renal cell carcinomas of pregnant women and their correlation with prognosis: a pilot study.

G Pomara1, G Salinitri, G Nesi, E Maio, A Minervini, A M Gammazza, F Francesca, F Cappello, C Selli.   

Abstract

In the present study, we reported two cases of renal cell carcinoma (RCC) diagnosed in pregnant women (Pt) that were submitted to radical nephrectomy, in both cases within the fourth month. The patients, after 13 and 3 years, respectively, did not show evidence of recurrent disease. We performed an immunohistochemical study on RCC specimens in comparison to seven age-matched controls (Cl). The panel of antibodies included Ki-67, p53, bcl-2, ER, PgR, PCNA, and IGF-1. We describe a difference in the expression of p53 and Ki-67. Specifically, p53 was highly expressed in RCC of both Pt but scarcely present or absent in Cl; by contrast, Ki-67 was hardly expressed or negative in RCC of both Pt, being commonly positive in Cl. These results may correlate with a good outcome of the disease in Pt. Although the limited number of cases did not permit any statistical evaluation, we postulate that these differences have not to be underestimated since they may disclose a correlation between pregnancy and biological behavior of tumoral disease. Further study may (dis)prove this hypothesis.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18070050     DOI: 10.1111/j.1525-1438.2007.00962.x

Source DB:  PubMed          Journal:  Int J Gynecol Cancer        ISSN: 1048-891X            Impact factor:   3.437


  2 in total

Review 1.  Renal cell carcinoma in pregnancy: a rare coexistence.

Authors:  S Boussios; N Pavlidis
Journal:  Clin Transl Oncol       Date:  2013-09-04       Impact factor: 3.405

2.  Kidney angiomyolipoma in pregnancy.

Authors:  Krzysztof Tupikowski; Aleksander Biały; Janusz Dembowski; Monika Złotkiewicz; Maciej Guziński; Anna Karina Kołodziej; Romuald Zdrojowy
Journal:  Cent European J Urol       Date:  2014-01-27
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.